Original Article

You have full text access to this OnlineOpen article

Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis

  1. Oscar Arrieta MD1,2,†,*,
  2. Jose Luis Rodriguez-Diaz MD1,
  3. Vanessa Rosas-Camargo MD1,
  4. Daniela Morales-Espinosa MD1,
  5. Sergio Ponce de Leon MD3,
  6. David Kershenobich MD2,4,
  7. Eucario Leon-Rodriguez MD5

Article first published online: 11 SEP 2006

DOI: 10.1002/cncr.22198

Issue

Cancer

Cancer

Volume 107, Issue 8, pages 1852–1858, 15 October 2006

Additional Information

How to Cite

Arrieta, O., Rodriguez-Diaz, J. L., Rosas-Camargo, V., Morales-Espinosa, D., de Leon, S. P., Kershenobich, D. and Leon-Rodriguez, E. (2006), Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis. Cancer, 107: 1852–1858. doi: 10.1002/cncr.22198

Author Information

  1. 1

    Department of Medical Oncology, Instituto Nacional de Cancerologia, Tlalpan, Mexico

  2. 2

    Universidad Nacional Autonoma de Mexico, Mexico City, Mexico

  3. 3

    Department of Internal Medicine, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico

  4. 4

    Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran, Mexico

  5. 5

    Department of Hemato-Oncology, Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran, Mexico

  1. †

    Fax: (011) 55 13151223.

*Department of Medical Oncology, Instituto Nacional de Cancerologia, San Fernando #22, Seccion XVI, Tlalpan, Mexico, D.F. C.P. 14080

Publication History

  1. Issue published online: 3 OCT 2006
  2. Article first published online: 11 SEP 2006
  3. Manuscript Accepted: 5 JUL 2006
  4. Manuscript Revised: 18 JUN 2006
  5. Manuscript Received: 16 DEC 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (112K)

REFERENCES

  • 1
    Okuda K. Hepatocellular carcinoma. J Hepatol. 2000; 32(S1): 225–237.
  • 2
    Aguayo A, Patt YZ. Liver cancer. Clin Liver Dis. 2001; 5: 479–507.
  • 3
    El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 2001; 33: 62–65.
    Direct Link:
  • 4
    Hasan F, Jeffers LJ, De Medina M, et al. Hepatitis-C associated hepatocellular carcinoma. Hepatology. 1990; 12: 589–591.
    Direct Link:
  • 5
    Nissen NN, Martin P. Hepatocellular carcinoma: the high risk patient. J Clin Gastroenterol. 2002; 35(5 Suppl 2 ): S79–85.
  • 6
    Monto A, Wright T. The epidemiology and prevention of hepatocellular carcinoma. Seminars Oncol. 2001; 28: 441–449.
  • 7
    Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum. 1998; 28: 48–59.
  • 8
    Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004; 4: 253–265.
  • 9
    Kershenobich D, Rojkind M, Quiroga A, Alcocer-Varela J. Effect of colchicine on lymphocytes and monocytes function and its relation to fibroblast proliferation in primary biliary cirrhosis. Hepatology. 1990; 11: 205–209.
    Direct Link:
  • 10
    Ehrlich HP, Bornstein P. Microtubules in transcellular movement of procollagen. Nat New Biol. 1972; 238: 257–260.
  • 11
    Harris EDJr., Krane SM. Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthritis Rheum. 1971; 14: 669–684.
    Direct Link:
  • 12
    Nava-Ocampo A, Suster S, Muriel P. Effect of colchicine and ursodeoxycholic acid on hepatocyte and erythrocyte membranes and liver experimentally induced carbon tetrachloride cirrhosis in rats. Eur J Clin Invest. 1997; 27: 77–84.
    Direct Link:
  • 13
    Rambaldi A, Gluud C. Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis. Liver. 2001; 21: 129–136.
    Direct Link:
  • 14
    Rambaldi A, Gluud C. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev. 2005; CD002148.
  • 15
    Morgan TR, Weiss DG, Nemchausky B, et al. Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. Gastroenterology. 2005; 128: 882–890.
  • 16
    Kershenobich D, Vargas F, Garcia-Tsao G, Perez-Tamayo R, Gent M, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med. 1988; 318: 1709–1713.
  • 17
    Velazquez R. Rodriguez M, Navascues CA, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003; 37: 520–527.
    Direct Link:
  • 18
    Ganne-Carrie N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology. 1996; 23: 1112–1118.
    Direct Link:
  • 19
    Rodriguez-Diaz J, Rosas-Camargo V, Vega-Vega O, et al. Clinical and pathologic factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus related cirrhosis: a long-term follow-up study. Clin Oncol. In press .
  • 20
    Aizawa Y, Shibamoto Y, Takagi I, et al. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C: a long-term follow-up study after histologic diagnosis. Cancer. 2000; 89: 53–59.
  • 21
    Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut. 2000; 47: 131–136.
  • 22
    Iwasaki Y, Takaguchi K, Ikeda H, et al. Risk factors for hepatocellular carcinoma in hepatitis C patients with sustained virologic response to interferon therapy. Liver Int. 2004; 24: 603–610.
    Direct Link:
  • 23
    Tanaka K, Sakai H, Hashizume M, et al. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Jpn J Cancer Res. 1998; 89: 1241–1250.
  • 24
    Cougot D, Neuveut C, Buendia MA. HBV induced carcinogenesis. J Clin Virol. 2005; 34( Suppl 1): S75–78.
  • 25
    Colombo M. Hepatitis C virus and hepatocellular carcinoma. Semin Liver Dis. 1999; 19: 263–269.
  • 26
    Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991; 325: 675–680.
  • 27
    Nakamoto Y, Kaneko S, Fan H, et al. Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy. J Exp Med. 2002; 196: 1105–1111.
  • 28
    Adhami JE, Basho J. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial. Panminerva Med. 1998; 40: 75–81.
  • 29
    Liu CY, Liao HF, Shih SC, et al. Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiation. World J Gastroenterol. 2005; 11: 4237–4240.
View Full Article (HTML) Get PDF (112K)